Literature DB >> 9521779

Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.

I L Urbatsch1, L Beaudet, I Carrier, P Gros.   

Abstract

Vanadate trapping of nucleotide and site-directed mutagenesis were used to investigate the role of the two nucleotide-binding (NB) sites in the regulation of ATP hydrolysis by P-glycoprotein (mouse Mdr3). Mdr3, tagged with a hexahistidine tail, was overexpressed in the yeast Pichia pastoris and purified to about 90% homogeneity by Ni-affinity chromatography. This protocol yielded purified, reconstituted Mdr3 which exhibited high verapamil stimulation of ATPase activity with a Vmax of 4.2 micromol min-1 mg-1 and a KM of 0.7 mM, suggesting that Mdr3 purified from P. pastoris is highly functional. Point mutations were introduced into the core consensus sequence of the Walker A or B motifs in each of the two NB sites. The mutants K429R, K1072R (Walker A) and D551N, D1196N (Walker B) were functionally impaired and unable to confer cellular resistance to the fungicide FK506 in the yeast Saccharomyces cerevisiae. Single and double mutants (K429R/K1072R, D551N/D1196N) were expressed in P. pastoris, and the effect of these mutations on the ATPase activity of Mdr3 was characterized. Purified reconstituted Mdr3 mutants showed no detectable ATPase activity compared to proteoliposomes purified from negative controls (<5% of wild-type Mdr3). Vanadate readily induced trapping of 8-azido-nucleotide in the wild-type enzyme after a short 10 s incubation, and specific photolabeling of Mdr3 after UV irradiation. No such vanadate-induced trapping/photolabeling was observed in any of the mutants, even after a 60 min trapping period at 37 degrees C. Since vanadate trapping with 8-azido-ATP requires hydrolysis of the nucleotide, the data suggest that 8-azido-ATP hydrolysis is dramatically impaired in all of the mutant proteins (<0.3% activity). These results show that mutations in either NB site prevent single turnover and vanadate trapping of nucleotide in the nonmutant site. These results further suggest that the two NB sites cannot function independently as catalytic sites in the intact molecule. In addition, the N- or C-terminal NB sites appear functionally indistinguishable, and cooperative interactions absolutely required for ATP hydrolysis may originate from both sites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521779     DOI: 10.1021/bi9728001

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism.

Authors:  H W van Veen; A Margolles; M Müller; C F Higgins; W N Konings
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Function of the Caenorhabditis elegans ABC transporter PGP-2 in the biogenesis of a lysosome-related fat storage organelle.

Authors:  Lena K Schroeder; Susan Kremer; Maxwell J Kramer; Erin Currie; Elizabeth Kwan; Jennifer L Watts; Andrea L Lawrenson; Greg J Hermann
Journal:  Mol Biol Cell       Date:  2007-01-03       Impact factor: 4.138

Review 3.  The mechanism of action of multidrug-resistance-linked P-glycoprotein.

Authors:  Z E Sauna; M M Smith; M Müller; K M Kerr; S V Ambudkar
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

4.  Strict coupling between CFTR's catalytic cycle and gating of its Cl- ion pore revealed by distributions of open channel burst durations.

Authors:  László Csanády; Paola Vergani; David C Gadsby
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

5.  Substitution of the Walker A lysine by arginine in the nucleotide-binding domains of sulphonylurea receptor SUR2B: effects on ligand binding and channel activity.

Authors:  Tobias Amann; Sophie Schell; Petra Kühner; Marcus Winkler; Mathias Schwanstecher; Ulrich Russ; Ulrich Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-30       Impact factor: 3.000

6.  In silico screening for inhibitors of p-glycoprotein that target the nucleotide binding domains.

Authors:  Frances K Brewer; Courtney A Follit; Pia D Vogel; John G Wise
Journal:  Mol Pharmacol       Date:  2014-09-30       Impact factor: 4.436

7.  Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein.

Authors:  Z E Sauna; S V Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

8.  Two neonatal diabetes mutations on transmembrane helix 15 of SUR1 increase affinity for ATP and ADP at nucleotide binding domain 2.

Authors:  David Ortiz; Peter Voyvodic; Lindsay Gossack; Ulrich Quast; Joseph Bryan
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 9.  The occluded nucleotide conformation of p-glycoprotein.

Authors:  Gregory Tombline; Alan E Senior
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 2.945

10.  Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.

Authors:  K Ueda; J Komine; M Matsuo; S Seino; T Amachi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.